1,050 results
·
28ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
REHASTIM & REHAMOVE
FDA 510(k)
FDA Class 2
·Neurology
REHASTIM 2, ERIGOPRO (FES)
FDA 510(k)
FDA Class 2
·Neurology
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ABBOTT CEA-EIA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-RIA MONOCLONAL
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ABBOTT CEA-EIA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ABBOTT CEA-EIA
EUROIMMUN PR3 ELISA KIT. EUROIMMUN MPO ELISA KIT.
FDA 510(k)
FDA Class 2
·Immunology
EUROIMMUN ANCA IFA GRANULOCYTE BIOCHIP MOSCAIC IGG ANTIBODY IN HUMAN SERUM
FDA 510(k)
FDA Class 2
·Immunology
VASOGENICS EECP-MC2
FDA 510(k)
FDA Class 2
·Cardiovascular
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ENZYMUN TEST{R} CEA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE TEST KIT
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE(R) EIA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ABBOTT CEA-EIA KIT
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE TEST KIT
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE TEST KIT
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE(R) EIA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE(R) EIA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE(R) EIA
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·CEA-ROCHE TEST KIT
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ABBOTT CEA-RIA MONOCLONAL